PPL
82
2
NOV
45
-5
DLTR
46
-5
LEN
11
-3
D
30
2
TDC
28
-6
MCHP
37
-5
NSC
39
-6
FIS
72
-5
PFE
35
-2
AIG
75
-3
WDC
33
-4
MTCH
22
-13
KEY
40
-6
AAL
20
-3
ABBV
59
4
MSFT
46
-7
KLAC
53
-5
FITB
55
-3
LYB
23
-4
PPL
82
2
NOV
45
-5
DLTR
46
-5
LEN
11
-3
D
30
2
TDC
28
-6
MCHP
37
-5
NSC
39
-6
FIS
72
-5
PFE
35
-2
AIG
75
-3
WDC
33
-4
MTCH
22
-13
KEY
40
-6
AAL
20
-3
ABBV
59
4
MSFT
46
-7
KLAC
53
-5
FITB
55
-3
LYB
23
-4
Financhill
Back

Recruit Holdings Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
22

RCRUY
Recruit Holdings

Last Price:
$10.35
Seasonality Move:
11.81%
Sell
43

ALNY
Alnylam Pharmaceuticals

Last Price:
$268.29
Seasonality Move:
7.6%
Sell
22
Recruit Holdings (RCRUY) is a Sell

Is Recruit Holdings a Buy, Sell or Hold?

  • The current Recruit Holdings [RCRUY] share price is $10.35. The Score for RCRUY is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • RCRUY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $268.46. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RCRUY Stock Price Chart

What is Recruit Holdings's stock price today?

  • The Recruit Holdings share price today is $10.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCRUY is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $268.46
    The current trend is moderately bullish and ALNY is experiencing slight buying pressure.

RCRUY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 26.58 Sell
Chaikin Money Flow: -697181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.91 - 12.39) Sell
Bollinger Bands (100): (11.98 - 14.38) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.41 Buy
Relative Strength Index (14 RSI): 55.64 Buy
Chaikin Money Flow: 78938 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.82 - 268.04) Buy
Bollinger Bands (100): (240.65 - 270.25) Buy

RCRUY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.85 Sell
20-day SMA: 11.45 Sell
50-day SMA: 12.74 Sell
200-day SMA: 12.41 Sell
8-day EMA: 10.85 Sell
20-day EMA: 11.41 Sell
50-day EMA: 12.31 Sell
200-day EMA: 12.07 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 271.33 Sell
20-day SMA: 255.41 Buy
50-day SMA: 259.88 Buy
200-day SMA: 253.94 Buy
8-day EMA: 268.64 Sell
20-day EMA: 261.32 Buy
50-day EMA: 257.88 Buy
200-day EMA: 244.57 Buy

Recruit Holdings Earnings Growth & RCRUY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Recruit Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):